To further investigate the role of TOX and its potential diagnostic value in lymphomas here we have evaluated the labeling of a new anti-TOX monoclonal antibody (mAb) that works on paraffin-embedded tissues from a large series of normal tissues and B- and T-cell neoplasms. Here, TOX is linked to lymphoma.